Loss of peroxisomal membrane proteins PEX13 and PEX14 disrupts fatty acid oxidation and drives lipid imbalance
Bioscience Reports · 17.06.2026 · 46 (6)
DOI: 10.1042/bsr20260048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 22.05.2026. Verfasst von Navia Vinoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hepatogenomics Research Group, Queensland University of Technology (QUT), QLD 4059, Australia. Hauptthemen laut MEDLINE: Fatty Acids, Membrane Proteins, Lipid Metabolism, Peroxisomes. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Queensland University of Technology (QUT), DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
Peroxisomal disorders arise from severe peroxisome dysfunction and are frequently linked to liver pathology. Metabolic dysfunction-associated steatotic liver disease, which affects up to 38% of adults worldwide, has driven extensive efforts to identify genes that contribute to its development. In the present study, we investigated the role of two peroxisomal membrane proteins, PEX13 and PEX14, by performing single and dual small interfering RNA-mediated knockdowns in a liver cell line, HUH-7. Steatosis was induced using free fatty acids, and changes in lipid-metabolism gene expression were assessed by quantitative real-time polymerase chain reaction. Knockdown efficiency reached 90% for both genes, and Oil-Red-O staining confirmed successful induction of steatosis. Both single and combined knockdown of PEX13 and PEX14 altered the expression of genes involved in lipid sensing, fatty acid uptake, synthesis, and oxidation. These findings suggest that peroxisomal dysfunction disrupts hepatic metabolic pathways, promoting increased fatty acid uptake and synthesis. Such alterations may contribute to the liver dysfunction observed in patients with peroxisome biogenesis disorders, highlighting the importance of peroxisomal integrity in maintaining lipid homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatogenomics Research Group, Queensland University of Technology (QUT), QLD 4059, Australia.
- Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), QLD 4059, Australia.
- Metallogenomics Laboratory, Queensland University of Technology (QUT), QLD 4059, Australia.
ORCID-Profile: Gary Huang, Daniel Wallace, V Nathan Subramaniam
Förderung
- Queensland University of Technology (QUT)
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Vinoy, N., Huang, G., Wallace, D., & Subramaniam, V. N. (2026). Loss of peroxisomal membrane proteins PEX13 and PEX14 disrupts fatty acid oxidation and drives lipid imbalance. Bioscience Reports, 46(6). https://doi.org/10.1042/bsr20260048
Vancouver
Vinoy N, Huang G, Wallace D, Subramaniam VN. Loss of peroxisomal membrane proteins PEX13 and PEX14 disrupts fatty acid oxidation and drives lipid imbalance. Bioscience Reports. 2026;46(6). doi:10.1042/bsr20260048
BibTeX
@article{Vinoy2026,
author = {Vinoy, Navia and Huang, Gary and Wallace, Daniel and Subramaniam, V Nathan},
title = {Loss of peroxisomal membrane proteins PEX13 and PEX14 disrupts fatty acid oxidation and drives lipid imbalance},
journal = {Bioscience Reports},
year = {2026},
volume = {46},
number = {6},
doi = {10.1042/bsr20260048}
}
EUVIMED